# Urologic Complications After Renal Transplant

## Introduction

Urologic complications affect between 2% and 15% of renal transplant recipients, making them the most frequent surgical issues following transplantation. These complications encompass urine leaks, ureteral obstruction, vesicoureteral reflux, lymphocele formation, vascular problems, and perinephric collections. Early identification and prompt management are essential to preserve the function of the transplanted kidney and prevent graft loss. Therefore, urologists must be well-versed in the clinical presentation, diagnostic approaches, and treatment strategies for each of these complications.

## Urine Leak (Urinary Fistula)

### Incidence and Timing

Urine leaks occur in approximately 2-5% of transplant recipients and are most commonly observed within the first two weeks after transplantation, classifying them as early complications. The most frequent site of leakage is the ureteroneocystostomy, which is the junction between the distal ureter and the bladder. Other less common sites include areas of ureteral necrosis due to devascularization, calyceal leaks, and the bladder closure site.

### Etiology

The primary cause of urine leaks is distal ureteral ischemia. The transplant ureter receives its blood supply exclusively from the renal artery via a ureteral branch; thus, excessive ureteral length or stripping of the periureteral tissue during surgery can lead to ischemia and subsequent necrosis of the distal ureter. Technical factors such as poor mucosal apposition, tension at the anastomosis, and inadequate suturing also contribute to leaks. The absence of a ureteral stent during transplantation significantly increases the risk, as stent placement reduces urine leak rates by about 50%. Additionally, rejection episodes and the use of high-dose steroids can impair wound healing, further predisposing to leaks.

### Clinical Presentation

Patients with urine leaks typically present with increased output from surgical drains, where the creatinine concentration in the drain fluid is higher than that in the serum, confirming the presence of urine. They may also exhibit decreasing urine output accompanied by rising serum creatinine levels. Physical signs include wound drainage, perinephric fluid collections, or swelling of the scrotum or labia. If the urine collection becomes infected, patients may develop pain and fever, indicating a urinoma.

### Diagnosis

Diagnosis involves fluid analysis showing drain fluid creatinine significantly exceeding serum creatinine, confirming urine leakage. Renal ultrasound can detect perinephric fluid collections. A nuclear renogram using MAG3 can demonstrate radiotracer extravasation or pooling outside the collecting system. Antegrade or retrograde pyelography helps localize the exact site of the leak. CT scans with delayed imaging may also reveal contrast extravasation.

### Management

Small leaks can often be managed conservatively with prolonged Foley catheter drainage for 7 to 14 days to decompress the bladder, along with ureteral stenting via retrograde or antegrade approaches if feasible. Percutaneous nephrostomy can divert urine away from the leak site to facilitate healing. Moderate leaks are typically treated with a combination of ureteral stenting and percutaneous drainage of any urinoma, with many resolving without surgery. Significant leaks or those that fail conservative management require surgical re-exploration. Surgical options include re-do ureteroneocystostomy if sufficient viable ureter remains, native ureter-to-transplant pelvis anastomosis (ureteropyelostomy) if the transplant ureter is necrotic—this is an excellent option using the patient’s own ureter—and Boari flap or psoas hitch procedures if ureteral length is inadequate.

<image>Diagnostic algorithm for suspected urine leak after renal transplant showing: initial drain fluid creatinine analysis, renal ultrasound for fluid collection, MAG3 renogram demonstrating extravasation, and management pathway from conservative (Foley drainage and stenting) to surgical re-exploration with options for ureteroneocystostomy revision, native ureteropyelostomy, or Boari flap, with decision points based on leak severity and response to conservative measures</image>

## Ureteral Obstruction

### Incidence and Timing

Ureteral obstruction occurs in 1-5% of patients within the first three months post-transplant, usually due to edema, blood clots, kinking, or technical errors at the anastomosis. Late obstruction, occurring after three months, affects 2-10% of recipients and is commonly caused by ischemic strictures, fibrosis, polyomavirus (BK virus) nephropathy, or extrinsic compression such as from a lymphocele.

### Etiology

The most common cause of late ureteral obstruction is ischemic ureteral stricture, resulting from inadequate blood supply to the distal ureter and subsequent segmental fibrosis. Lymphoceles can cause extrinsic compression of the ureter. Early postoperative obstruction may result from blood clots, which often resolve with hydration and observation. BK polyomavirus nephropathy can cause ureteral inflammation and strictures; diagnosis is supported by the presence of decoy cells in the urine and elevated BK viral load in serum. Technical errors during implantation, such as kinking, torsion, or angulation of the ureter, also contribute to obstruction.

### Clinical Presentation

The earliest sign of ureteral obstruction is often a rising serum creatinine level. Decreased urine output may be subtle if the native kidneys still contribute residual function. Hydronephrosis detected on ultrasound is a key imaging finding, although mild hydronephrosis can be normal in the early post-transplant period. Many cases are asymptomatic, making routine surveillance with creatinine measurements and ultrasound critical.

### Diagnosis

Renal ultrasound typically reveals hydronephrosis and may show elevated resistive indices. MAG3 renography demonstrates an obstructive pattern with delayed excretion. Antegrade nephrostography, performed via percutaneous nephrostomy, can localize the level and severity of obstruction. Retrograde pyelography may be technically difficult due to altered ureteral orifice anatomy after transplantation.

### Management

Acute obstruction caused by blood clots is managed conservatively with observation, Foley catheter drainage, and hydration. Percutaneous nephrostomy provides emergent drainage if graft function deteriorates, stabilizing the situation. Balloon dilation and ureteral stenting are first-line treatments for short, non-ischemic strictures, with success rates between 50% and 70% for benign strictures. Endoureterotomy, involving incision of the stricture with a holmium laser or cold knife, can be used adjunctively. Surgical repair is reserved for long or ischemic strictures or cases that fail endoscopic management. Surgical options include revision ureteroneocystostomy with a psoas hitch or native ureteropyelostomy, which offers excellent long-term success exceeding 90% and avoids manipulation of the transplant hilum. If extrinsic compression from a lymphocele is the cause, drainage or marsupialization of the lymphocele is indicated.

## Lymphocele

### Incidence and Presentation

Lymphoceles develop in 1-26% of transplant recipients, although only 5-8% are clinically significant. They arise from disruption of lymphatic channels during dissection of the recipient’s iliac vessels. Lymphoceles typically present between two and six weeks post-transplant. Symptoms include ipsilateral leg edema, graft dysfunction due to ureteral compression, deep vein thrombosis, and wound bulging. Many lymphoceles are asymptomatic and do not require treatment.

### Diagnosis

Ultrasound reveals an anechoic fluid collection separate from the allograft, usually located medial or inferior to the kidney. CT scanning confirms the location and relationship of the lymphocele to the ureter. Analysis of aspirated fluid shows low creatinine levels (distinguishing it from urine), low triglycerides (excluding chyle), and a lymphocyte-predominant cell count.

### Management

Asymptomatic lymphoceles are managed with observation. Percutaneous drainage has a high recurrence rate of 50-80%, although sclerotherapy with agents such as povidone-iodine, bleomycin, or ethanol may be added. Definitive treatment is laparoscopic peritoneal window creation (marsupialization), which establishes communication between the lymphocele and the peritoneal cavity for internal drainage and has a success rate exceeding 90%. Open marsupialization is reserved for cases where laparoscopy is not feasible.

<image>Ultrasound image of a transplant kidney in the right iliac fossa showing a large anechoic lymphocele compressing the transplant ureter causing proximal hydronephrosis, with labeled anatomy including the transplant kidney, dilated renal pelvis, compressed ureter, lymphocele cavity, and external iliac vessels</image>

## Vascular Complications

Renal artery thrombosis occurs in 0.5-3.5% of transplant recipients, most commonly within the first week after surgery. It is caused by technical errors such as intimal flaps or kinking, hypercoagulable states, or severe rejection. Clinically, it presents as abrupt anuria or severe oliguria, with absent flow on Doppler ultrasound. Management requires emergent surgical exploration and thrombectomy within hours; graft salvage is unlikely if diagnosis is delayed, often necessitating graft nephrectomy.

Renal vein thrombosis has an incidence of 0.5-4% and results from compression by hematoma or lymphocele, kinking of the vein, hypercoagulability, or dehydration. It presents with sudden graft swelling, tenderness, hematuria, decreased urine output, and reversed diastolic flow on Doppler ultrasound. Emergent thrombectomy or thrombolysis is required, but graft loss is common if treatment is delayed.

Renal artery stenosis occurs in 1-23% of recipients, with variability due to differing diagnostic criteria. It typically presents between three months and two years post-transplant. Causes include intimal hyperplasia at the anastomosis, recipient vessel atherosclerosis, and clamp injury. Patients present with refractory hypertension, graft dysfunction, and a bruit over the graft. Diagnosis is made by Doppler ultrasound showing peak systolic velocity greater than 200 cm/s and a tardus-parvus waveform, confirmed by CT or MR angiography. Management involves percutaneous transluminal angioplasty with or without stenting as first-line therapy, with surgical revision reserved for failed angioplasty.

Pseudoaneurysms and arteriovenous (AV) fistulae usually arise as complications of biopsy. Small pseudoaneurysms may be observed, while symptomatic ones require angioembolization. Most AV fistulae resolve spontaneously, but large or symptomatic fistulae may also require angioembolization.

| Complication | Incidence | Timing | First-Line Management | Definitive Treatment |
|---|---|---|---|---|
| Urine leak | 2-5% | <2 weeks | Foley drainage + stenting | Surgical revision (ureteroneocystostomy or ureteropyelostomy) |
| Ureteral obstruction (early) | 1-5% | <3 months | Percutaneous nephrostomy; stenting | Balloon dilation or surgical repair |
| Ureteral obstruction (late) | 2-10% | >3 months | Nephrostomy + stent/dilation | Native ureteropyelostomy or revision reimplantation |
| Lymphocele (symptomatic) | 5-8% | 2-6 weeks | Percutaneous drainage (+/- sclerotherapy) | Laparoscopic marsupialization (>90% success) |
| Renal artery thrombosis | 0.5-3.5% | <1 week | Emergent exploration + thrombectomy | Graft nephrectomy if delayed |
| Renal vein thrombosis | 0.5-4% | Early | Thrombectomy/thrombolysis | Graft loss common if delayed |
| Renal artery stenosis | 1-23% | 3 mo - 2 yr | Percutaneous angioplasty +/- stent | Surgical revision if failed |

## Other Complications

Perinephric hematomas are common within the first 48 hours after transplantation and are usually self-limited. Surgical exploration is indicated if the hematoma is hemodynamically significant, expanding, or compressing the graft.

Wound complications include incisional hernias, which occur in 2-5% of patients, as well as wound infections and dehiscence. These risks are increased in patients with obesity, diabetes, and those receiving steroids.

Urolithiasis in the transplant kidney occurs in 1-2% of recipients and may present as graft dysfunction or urinary tract infection. Because the transplant kidney is denervated, patients typically do not experience the classic renal colic. Diagnosis is made by ultrasound or CT. Management options include ureteroscopy, although retrograde access can be challenging due to altered anatomy. Percutaneous nephrostomy with an antegrade approach or flexible ureteroscopy via the neocystostomy orifice may also be employed.

<image>Duplex Doppler ultrasound images comparing normal transplant renal artery waveform with rapid systolic upstroke and low resistance versus transplant renal artery stenosis showing elevated peak systolic velocity greater than 200 cm/s with turbulent flow, and a distal intrarenal segmental artery with tardus-parvus waveform indicating hemodynamically significant proximal stenosis</image>

## Key Clinical Pearls

Placement of a ureteral stent at the time of transplantation reduces urine leak rates by approximately 50% and is standard practice at most centers. The blood supply to the transplant ureter originates solely from the renal artery, making excessive ureteral length and stripping of the periureteral adventitia the primary causes of ischemic complications. A rising serum creatinine in a transplant recipient should prompt immediate renal ultrasound to assess for hydronephrosis indicating obstruction, fluid collections such as urinoma or lymphocele, and vascular flow abnormalities including thrombosis or stenosis. Native ureteropyelostomy is an excellent salvage option for transplant ureteral complications, as it avoids reoperation in the transplant hilum. For symptomatic lymphoceles, laparoscopic peritoneal window creation (marsupialization) is the definitive treatment because percutaneous drainage alone has an unacceptably high recurrence rate. Transplant renal artery stenosis should be suspected in any recipient with refractory hypertension, and Doppler ultrasound serves as the initial screening test.

## References

1. Slagt IK, Ijzermans JN, Visser LJ, et al. Urological complications after kidney transplantation: a systematic review. *Transpl Int*. 2023;36:11188.  
2. Streeter EH, Little DM, Cranston DW, Morris PJ. The urological complications of renal transplantation: a series of 1535 patients. *BJU Int*. 2002;90(7):627-634.  
3. Eufrasio P, Parada B, Moreira P, et al. Surgical complications in 2000 renal transplants. *Transplant Proc*. 2011;43(1):142-144.  
4. Saidi RF, Wertheim JA, Ko DS, et al. Impact of donor kidney recovery method on lymphatic complications in kidney transplantation. *Transplant Proc*. 2008;40(4):1054-1055.